Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases

Blood

Volumn 88, Issue 6, 1996, Pages 1930-1935

  Le Beau, Michelle M ^a   Espinosa III, Rafael ^b   Davis, Elizabeth M ^b   Eisenbart, James D ^b   Larson, Richard A ^b   Green, Eric D ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 7; CHROMOSOME 7Q; CHROMOSOME DELETION; CYTOGENETICS; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ACUTE DISEASE; BASE SEQUENCE; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 7; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; MOLECULAR SEQUENCE DATA; MYELODYSPLASTIC SYNDROMES;

EID: 0029821113     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Le Beau MM, Rowley JD: Cytogenetics, in Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds): Hematology. New York, NY, McGraw-Hill, 1995, p 98
2. Mitelman F (ed): Catalog of Chromosome Abnormalities in Cancer (ed 5). New York, NY, Wiley-Liss, 1995
3. Mitelman F, Kaneko Y, Berger, R: Report of the committee on chromosome changes in neoplasia, in Cuticchia AJ, Pearson PL (eds): Human Gene Mapping. Baltimore, MD, Johns Hopkins, 1993, p 773
4. Rabbitts TH: Chromosome translocations in human cancer. Nature 372:143, 1994
5. Weinberg RA: Tumor suppressor genes. Science 254:1138, 1991
6. Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci USA 90:10914, 1993
7. Levine AJ: The tumor suppressor genes. Ann Rev Biochem 62:623, 1993
8. Johansson B, Mertens F, Mitelman F: Cytogenetic deletion maps of hematologic neoplasms: Circumstantial evidence for tumor suppressor loci. Genes Chromosomes Cancer 8:205, 1993
9. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F: Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597, 1994
10. Jacks T, Shih S, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumorigenic and developmental consequences of a targeted Nf1 mutation in the mouse. Nat Genet 7:353, 1994
11. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG: Nf1 deficiency causes Ras-mediated granulocyte-macrophage colony-stimulating factor hypersensitivity and chronic myeloid leukemia. Nat Genet 12:137, 1996
12. Bollag G, Clapp DW, Shih S, Adler F, Zhang Y, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K: Loss of Nf1 results in activation of the Ras signaling pathway and leads to aberrant growth in murine and human hematopoietic cells. Nat Genet 12:144, 1996
13. Le Beau MM, Espinosa III R, Neuman WL, Stock W, Roulston D, Larson RA, Keinanen M, Westbrook CA: Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci USA 90:5484, 1993
14. Kobayashi HK, Espinosa III R, Fernald AA, Begy C, Diaz MO, Le Beau MM, Rowley JD: Analysis of the deletions of the long arm of chromosome 11 in hematologic malignancies with fluorescence in situ hybridization. Genes Chromosomes Cancer 8:246, 1993
15. Roulston D, Espinosa III R, Stoffel M, Bell GI, Le Beau MM: Molecular genetics of myeloid leukemia: Identification of the commonly deleted segment of chromosome 20. Blood 82:3424, 1993
16. Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Davis EM, Le Beau MM, Roberts JM, Vogelstein B, Rowley JD, Bohlander SK: TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 86:1525, 1995
17. Luna-Fineman S, Shannon KM, Lange BJ: Childhood monosomy 7: Epidemiology, biology, and mechanistic implications. Blood 85:1985, 1995
18. Fourth International Workshop on Chromosomes in Leukemia 1982. Cancer Genet Cytogenet 11:249, 1984
19. Le Beau MM, Albain KS, Larson RA , Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes 5 and 7. J Clin Oncol 4:325, 1986
20. Pedersen-Bjergaard J, Rowley JD: The balanced and unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780, 1994
21. Thirman MJ, Larson RA: Therapy-related myeloid leukemia. Hematol Oncol Clin North Am 10:293, 1996
22. Mitelman F (ed): ISCN (1995): An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
23. Green ED, Idol JR, Mohr-Tidwell R, Braden VV, Peluso DC, Fulton RS, Massa HF, Magness CL, Wilson AM, Kimura J, Weissenbach J, Trask BJ: Integration of physical, genetic, and cytogenetic maps of human chromosome 7: Isolation and analysis of yeast artificial chromosome clones for 117 mapped genetic markers. Hum Mol Genet 3:489, 1994
24. Moir DT, Smith DR: Chapter 5: Large-insert cloning and analysis, in Dracopoli NC, Haines JL, Korf BR, Moir DT, Morton CC, Seidman CE, Seidman JG, Smith DR (eds): Currrent Protocols in Human Genetics, vol 1. New York, NY, Wiley-Liss, 1994, p 5.05
25. Lengauer C, Green ED, Cremer T: Fluorescence in situ hybridization of YAC clones after Alu-PCR amplification. Genomics 13:826, 1992
26. Liu P, Siciliano J, Seong D, Craig J, Zhao Y, de Jong PJ, Siciliano MJ: Dual Alu polymerase chain reaction primers and conditions for isolation of human chromosome painting probes from hybrid cells. Cancer Genet Cytogenet 65:93, 1993
27. Rowley JD, Diaz MO, Espinosa R, Patel YD, van Melle E, Ziemin S, Taillon-Miller P, Lichter P, Evans GA, Kersey JD, Ward DC, Domer PH, Le Beau MM: Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: Identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA 87:9358, 1990
28. Green ED, Green P: Sequence-tagged site (STS) content mapping of human chromosomes: theoretical considerations and early experiences. PCR Methods Appl 1:77, 1991
29. Green ED, Mohr RM, Idol JR, Jones M, Buckingham JM, Deaven LL, Moyzis RK, Olson MV: Systematic generation of sequence-tagged sites for physical mapping of human chromosomes: Application to the mapping of human chromosome 7 using yeast artificial chromosomes. Genomics 11:548, 1991
30. Green ED, Braden VV, Fulton RS, Lim R, Ueltzen MS, Peluso DC, Mohr-Tidwell RM, Idol JR, Smith LM, Chumakov I, Le Paslier D, Cohen D, Featherstone T, Green P: A human chromosome 7 yeast artificial chromosome (YAC) resource: Construction, characterization, and screening. Genomics 25:170, 1995
31. Tsui L-C, Donis-Keller H, Grzeschik K-H: Report of the second international workshop on human chromosome 7 mapping 1994. Cytogenet Cell Genet 71:1, 1995
32. Kere J, Ruutu T, Lahtinen R, de la Chapelle: Molecular characterizations of chromosomal deletions in myeloid disorders. Blood 70:1349, 1987
33. Kere J, Donis-Keller H, Ruutu T, de la Chapelle: Chromosome 7 long arm deletions in myeloid disorders: Terminal DNA sequences are commonly conserved and breakpoints vary. Cytogenet Cell Genet 50:226, 1989
34. Lewis S, Boultwood J, Fidler C, Sheridan H, Said S, Buckle V, Wainscoat J: Molecular mapping of the 7q deletion in myeloid disorders. Blood 82:34a, 1993 (abstr, suppl 1)
35. Fischer K, Fröhling S, Scherer SW, Scholl C, Schlegelberger B, Bentz M, Tsui L-C, Lichter P, Döhner H: Heterogeneity of 7q22 deletion and translocation breakpoints in myeloid leukemias. Blood 86:43a, 1995 (abstr, suppl 1)
36. Tosi S, Scherer SW, Rambaldi A, Hashim Y, Wainscoat JS, Osborne L, Biondi A, Tsui L-C, Kearney L: Characterization of 7q abnormalities in the human myeloid leukemia cell line GFD8 by fluorescence in situ hybridization (FISH). Cytogenet Cell Genet 71:28, 1995 (abstr)
37. Kiuru-Kuhlefelt S, Knuutila S, Kere J: Loss of heterozygosity in acute myeloid leukemia and myelodysplastic syndrome at 7q. Am J Hum Genet 57:363, 1995 (abstr)
38. Liang H, Fairman J, Claxton D, Chumakov I, Nagarajan L: Molecular analysis of chromosome 7 deletions in myelodysplastia and acute myeloid leukemia. Blood 86:169a, 1995 (abstr, suppl 1)
39. Johnson EJ, Scherer SW, Osborne L, Tsui L-C, Oscier D, Mould S, Cotter FE: Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. Blood 86:270a, 1995 (abstr, suppl 1)